- $441.06m
- $372.05m
- $34.16m
- 45
- 24
- 39
- 28
Annual income statement for OmniAB, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.3 | 23.3 | 34.7 | 59.1 | 34.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31.3 | 48.9 | 70.4 | 85.7 | 104 |
Operating Profit | -13 | -25.6 | -35.6 | -26.6 | -69.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13 | -23.7 | -34.4 | -26.1 | -64.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.6 | -17.6 | -27 | -22.3 | -50.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.6 | -17.6 | -27 | -22.3 | -50.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.6 | -17.6 | -27 | -22.3 | -50.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.118 | -0.152 | -0.235 | -0.194 | -0.508 |